165 related articles for article (PubMed ID: 10447964)
1. Robust QSAR models using Bayesian regularized neural networks.
Burden FR; Winkler DA
J Med Chem; 1999 Aug; 42(16):3183-7. PubMed ID: 10447964
[TBL] [Abstract][Full Text] [Related]
2. Use of automatic relevance determination in QSAR studies using Bayesian neural networks.
Burden FR; Ford MG; Whitley DC; Winkler DA
J Chem Inf Comput Sci; 2000; 40(6):1423-30. PubMed ID: 11128101
[TBL] [Abstract][Full Text] [Related]
3. Bayesian regularization of neural networks.
Burden F; Winkler D
Methods Mol Biol; 2008; 458():25-44. PubMed ID: 19065804
[TBL] [Abstract][Full Text] [Related]
4. Robust fuzzy mappings for QSAR studies.
Kumar M; Thurow K; Stoll N; Stoll R
Eur J Med Chem; 2007 May; 42(5):675-85. PubMed ID: 17316911
[TBL] [Abstract][Full Text] [Related]
5. Ensembles of Bayesian-regularized genetic neural networks for modeling of acetylcholinesterase inhibition by huprines.
Fernández M; Caballero J
Chem Biol Drug Des; 2006 Oct; 68(4):201-12. PubMed ID: 17105484
[TBL] [Abstract][Full Text] [Related]
6. Broad-based quantitative structure-activity relationship modeling of potency and selectivity of farnesyltransferase inhibitors using a Bayesian regularized neural network.
Polley MJ; Winkler DA; Burden FR
J Med Chem; 2004 Dec; 47(25):6230-8. PubMed ID: 15566293
[TBL] [Abstract][Full Text] [Related]
7. Evolutionary optimization in quantitative structure-activity relationship: an application of genetic neural networks.
So SS; Karplus M
J Med Chem; 1996 Mar; 39(7):1521-30. PubMed ID: 8691483
[TBL] [Abstract][Full Text] [Related]
8. 2D Autocorrelation modeling of the negative inotropic activity of calcium entry blockers using Bayesian-regularized genetic neural networks.
Caballero J; Garriga M; Fernández M
Bioorg Med Chem; 2006 May; 14(10):3330-40. PubMed ID: 16442799
[TBL] [Abstract][Full Text] [Related]
9. QSAR modeling of anti-invasive activity of organic compounds using structural descriptors.
Katritzky AR; Kuanar M; Dobchev DA; Vanhoecke BW; Karelson M; Parmar VS; Stevens CV; Bracke ME
Bioorg Med Chem; 2006 Oct; 14(20):6933-9. PubMed ID: 16908166
[TBL] [Abstract][Full Text] [Related]
10. Anticancer activity of selected phenolic compounds: QSAR studies using ridge regression and neural networks.
Nandi S; Vracko M; Bagchi MC
Chem Biol Drug Des; 2007 Nov; 70(5):424-36. PubMed ID: 17949360
[TBL] [Abstract][Full Text] [Related]
11. ANN-QSAR model of drug-binding to human serum albumin.
Deeb O; Hemmateenejad B
Chem Biol Drug Des; 2007 Jul; 70(1):19-29. PubMed ID: 17630991
[TBL] [Abstract][Full Text] [Related]
12. QSAR modeling of mono- and bis-quaternary ammonium salts that act as antagonists at neuronal nicotinic acetylcholine receptors mediating dopamine release.
Zheng F; Bayram E; Sumithran SP; Ayers JT; Zhan CG; Schmitt JD; Dwoskin LP; Crooks PA
Bioorg Med Chem; 2006 May; 14(9):3017-37. PubMed ID: 16431111
[TBL] [Abstract][Full Text] [Related]
13. QSAR modeling of human serum protein binding with several modeling techniques utilizing structure-information representation.
Votano JR; Parham M; Hall LM; Hall LH; Kier LB; Oloff S; Tropsha A
J Med Chem; 2006 Nov; 49(24):7169-81. PubMed ID: 17125269
[TBL] [Abstract][Full Text] [Related]
14. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
[TBL] [Abstract][Full Text] [Related]
15. Neural networks in building QSAR models.
Baskin II; Palyulin VA; Zefirov NS
Methods Mol Biol; 2008; 458():137-58. PubMed ID: 19065809
[TBL] [Abstract][Full Text] [Related]
16. QSAR modeling of matrix metalloproteinase inhibition by N-hydroxy-alpha-phenylsulfonylacetamide derivatives.
Fernández M; Caballero J
Bioorg Med Chem; 2007 Sep; 15(18):6298-310. PubMed ID: 17590339
[TBL] [Abstract][Full Text] [Related]
17. Bayesian-regularized genetic neural networks applied to the modeling of non-peptide antagonists for the human luteinizing hormone-releasing hormone receptor.
Fernández M; Caballero J
J Mol Graph Model; 2006 Dec; 25(4):410-22. PubMed ID: 16574448
[TBL] [Abstract][Full Text] [Related]
18. Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds.
Prado-Prado FJ; González-Díaz H; de la Vega OM; Ubeira FM; Chou KC
Bioorg Med Chem; 2008 Jun; 16(11):5871-80. PubMed ID: 18485714
[TBL] [Abstract][Full Text] [Related]
19. Comparative study of QSAR/QSPR correlations using support vector machines, radial basis function neural networks, and multiple linear regression.
Yao XJ; Panaye A; Doucet JP; Zhang RS; Chen HF; Liu MC; Hu ZD; Fan BT
J Chem Inf Comput Sci; 2004; 44(4):1257-66. PubMed ID: 15272833
[TBL] [Abstract][Full Text] [Related]
20. Modeling the toxicity of chemicals to Tetrahymena pyriformis using heuristic multilinear regression and heuristic back-propagation neural networks.
Kahn I; Sild S; Maran U
J Chem Inf Model; 2007; 47(6):2271-9. PubMed ID: 17985864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]